Exacis Biotherapeutics Included on Inside Precision Medicine’s Five RNA Therapeutics Startups to Watch in 2022 List
Five RNA Therapeutics Startups to Watch in 2022
Advanced Therapies Conference to Include Gene Modified Therapy Track – Exacis Biotherapeutics CEO to Participate in Panel Discussion
Dr. Gregory Fiore, Co-Founder, President and CEO of Exacis Biotherapeutics will serve on a panel exploring the difference between autologous and allogeneic stem cell therapies during the Advanced Therapies Conference.
Cancer Progress Conference to Present Cost-Benefit Considerations for Complex Therapeutics- Panelists Include Exacis Biotherapeutics CEO
Dr. Gregory Fiore, Co-Founder, President and CEO of Exacis Biotherapeutics will discuss strategies for optimal positioning of new therapies as a panel member at the Cancer Progress Conference.
Exacis Biotherapeutics CEO to Serve on Expert Panel at Longwood Healthcare Leaders Meeting
Dr. Gregory Fiore, Co-Founder, President and CEO of Exacis Biotherapeutics will join of an expert panel of biotherapeutic leaders to discuss “Aligning Priorities with the Board” during the Longwood Healthcare Leaders Meeting.